Perinatal outcomes for the ACS and No-ACS groups
| Singletons | Twins | |||||
| ACS (n=314) | No-ACS (n=530) | P value | ACS (n=52) | No-ACS (n=158) | P value | |
| Outcomes | N (%) | N (%) | N (%) | N (%) | ||
| Perinatal mortality | 42 (13.4) | 151 (28.5) | <0.001 | 8 (15.4) | 43 (27.2) | 0.059 |
| Respiratory distress syndrome * | 58 (18.8) | 109 (25.8) | 0.026 | 6 (12.0) | 40 (28.4) | 0.013 |
*Denominator included live infants only, singletons (ACS 308 vs No-ACS 422) and twins (ACS 50 vs No-ACS 141).
†
‡Values in bold indicate statistically significant results
ACS, antenatal corticosteroids.